Chronic lymphocytic leukemia (CLL) and prolymphocytic leukemia (PLL) are types of blood cancer. They develop in types of white blood cells called B cells or T cells, or the precursors to these cells.

B-PLL is a rare subtype that’s more aggressive than other blood cancers and has a low survival rate. However, ongoing research and clinical trials may offer new treatment options to improve outcomes.

To confirm a diagnosis and determine the stage of the disease, your doctor will use a series of tests: Biopsy: This is the most definitive test. A surgeon will remove all or part of an affected lymph ...

Sjögren disease, which is an autoimmune condition, may increase a person’s risk of developing non-Hodgkin’s lymphoma (NHL). NHL is a type of cancer that starts in white blood cells — lymphocytes — and ...

Dear Dr. Roach: I’m 71 years old. In 2021, lymphocytosis was found during my pre-op workup for breast cancer. I had a successful lumpectomy and radiation, and I am on a five-year course of anastrozole ...

Open-Source Hybrid Large Language Model Integrated System for Extraction of Breast Cancer Treatment Pathway From Free-Text Clinical Notes The diagnosis of chronic lymphocytic leukemia (CLL) is often ...

Scientists provide a comprehensive overview of the evolution and potential of TIL therapy. They describe its development and highlight its transformative potential. The recent U.S. Food and Drug ...